How to titrate Mixtard (premixed insulin containing 30% soluble insulin and 70% isophane insulin) in a patient with uncontrolled type 2 diabetes mellitus (T2DM) and no significant renal or hepatic impairment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

How to Titrate Mixtard in Uncontrolled Type 2 Diabetes

Initial Dosing Strategy

Start Mixtard at 12 units twice daily (before breakfast and dinner), or calculate 0.3 units/kg/day total and split evenly between the two doses, given the uncontrolled state. 1, 2

  • For patients with severe hyperglycemia (A1C ≥9% or blood glucose ≥300 mg/dL), premixed insulin like Mixtard provides both basal and prandial coverage from the outset, which is more appropriate than basal-only approaches 1, 3
  • Continue metformin unless contraindicated, as it reduces total insulin requirements and provides complementary glucose-lowering effects 1, 4

Titration Algorithm

Increase the total daily dose by 2-4 units every 3 days based on fasting and pre-dinner glucose readings until targets are achieved. 1, 4

Specific Adjustment Protocol:

  • If fasting glucose ≥180 mg/dL: Increase the morning Mixtard dose by 4 units every 3 days 4
  • If fasting glucose 140-179 mg/dL: Increase the morning Mixtard dose by 2 units every 3 days 4
  • If pre-dinner glucose ≥180 mg/dL: Increase the evening Mixtard dose by 4 units every 3 days 4
  • If pre-dinner glucose 140-179 mg/dL: Increase the evening Mixtard dose by 2 units every 3 days 4

Target Goals:

  • Fasting and pre-meal glucose: 80-130 mg/dL 1, 3
  • Two-hour postprandial glucose: <180 mg/dL 3

Monitoring Requirements

Daily self-monitoring of fasting blood glucose and pre-dinner glucose is essential during the titration phase. 1, 4

  • Check A1C every 3 months during intensive titration 4
  • Assess adequacy of insulin dose at every clinical visit 4
  • If hypoglycemia occurs, reduce the corresponding dose by 10-20% immediately 1, 4

When to Advance Beyond Twice-Daily Mixtard

If A1C remains above target after 3-6 months of optimized twice-daily Mixtard, consider switching to thrice-daily premixed insulin analogues (70/30 aspart or 75/25 lispro) or transitioning to basal-bolus therapy. 2

  • Thrice-daily premixed insulin analogues have been found noninferior to basal-bolus regimens with similar hypoglycemia rates 2
  • Alternatively, consider switching to basal insulin plus GLP-1 receptor agonist for better weight control and reduced hypoglycemia risk 2

Critical Pitfalls to Avoid

Do not delay insulin intensification if glucose remains in the 200s mg/dL despite titration—this indicates need for more aggressive therapy or regimen change. 1, 4

  • Mixtard's pharmacodynamic profile is less optimal than rapid-acting insulin analogues, making postprandial control more challenging 2
  • Regular insulin (the soluble component of Mixtard) requires administration 30 minutes before meals, not at mealtime like analogues 5, 6
  • Premixed insulin offers less flexibility in meal planning compared to basal-bolus regimens 2
  • Do not continue escalating Mixtard indefinitely without reassessing the regimen—if total daily dose exceeds 1.0 units/kg/day without achieving targets, switch to a more intensive regimen 1, 4

Patient Education Essentials

Teach proper injection technique, hypoglycemia recognition and treatment, and the importance of consistent meal timing with Mixtard. 1, 4

  • Mixtard requires more rigid meal timing than insulin analogues due to the regular insulin component 5, 6
  • Instruct patients to administer Mixtard 30 minutes before breakfast and dinner 5, 6
  • Educate on treating hypoglycemia with 15 grams of fast-acting carbohydrate 4
  • Emphasize insulin storage, handling, and site rotation 4

Related Questions

Is Novolin 70/30 (insulin NPH and insulin regular) the same as Humulin 70/30 (insulin NPH and insulin regular) for a patient with diabetes?
What is the difference between Isophane (NPH insulin) 40 and Human Mixtard (biphasic insulin) 30/70 in terms of glucose control?
What is the best alternative to insulin lispro protamine-insulin lispro (HumaLOG MIX 75/25 KWIKPEN) (75-25) 100 units/mL injection pen?
What alternatives are available if a patient taking Humulin 70/30 (human insulin NPH 70%/regular 30%) 30 units twice daily before meals cannot obtain that specific insulin from the pharmacy?
How should I convert a patient on 175 units daily of premixed 70/30 insulin (70 % NPH, 30 % regular) to a regimen with 60 % basal insulin and 40 % rapid‑acting insulin using high‑concentration insulin?
Which azoles are ineffective in treating Mucor infections, specifically mucormycosis?
How to administer Mixtard (insulin) to a patient with diabetes?
When is Continuous Renal Replacement Therapy (CRRT) recommended in patients with severe rhabdomyolysis, particularly those with Acute Kidney Injury (AKI) or significant electrolyte imbalance?
What is the recommended dose of Cabgolin (cabergoline) for the prevention or treatment of Ovarian Hyperstimulation Syndrome (OHSS)?
Can a patient with a stroke and an ASPECTS (Alberta Stroke Programme Early Computed Tomography Score) score of less than 5 undergo thrombolysis with tPA (tissue plasminogen activator)?
What is a normal cortisol level in a healthy adult in the evening?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.